Five attorneys, one science advisor and two paralegals join the firm’s Intellectual Property Litigation Practice in Boston
BOSTON, Oct. 3, 2005 – Goodwin Procter LLP, a leading national law firm with offices in Boston, New York and Washington, DC, today announced that a team of attorneys and staff from Boston-based law firm Palmer & Dodge are joining the firm’s Intellectual Property Litigation Practice in Boston. The team will start at the firm in October.
Goodwin Procter’s Intellectual Property Litigation Practice and the team from Palmer & Dodge have one large client in common – Teva Pharmaceuticals Inc., which is among the top 20 pharmaceutical companies and among the largest generic pharmaceutical companies in the world. “The addition of this top Palmer & Dodge team to Goodwin Procter will strengthen the firm’s already formidable Intellectual Property Litigation Practice and offer Teva and our other IP clients an even deeper bench of support for their legal needs,” said Regina M. Pisa, chairman and managing partner at Goodwin Procter.
Michelle Ming Deng join the firm as associates. All of their practices will focus on patent litigation issues as they relate to the pharmaceutical industry.
Justine Leach, who earned a Master’s degree from MIT in physical chemistry, joins Goodwin Procter as a science advisor. Kevin Budris and Scott Lemke join the firm as paralegals.
Goodwin Procter’s patent and intellectual property litigation expertise has grown significantly over the last several years. Currently, the firm has more than 60 full time patent litigators, with a similar number of attorneys handling IP licensing and transactional work. With the Palmer & Dodge additions, the firm has eight science advisors and 17 staff members with Ph.D.s, primarily in the chemical, medical and electrical areas, to support litigation and opinion writing.